Mycovia Pharmaceuticals to Present at 2019 BIO Investor Forum

CEO Patrick Jordan to highlight the need for increased industry focus and investment in advancing women’s health

Company selected to present as a “Buzz of BIO” Late Stage Leader

Durham, N.C. – October 21, 2019 – Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced that Chief Executive Officer Patrick Jordan will present at the 2019 BIO Investor Forum being held October 22-23 at the Westin St. Francis in San Francisco, Calif. The BIO Investor Forum, an international investor conference focused on early and established private companies as well as emerging public companies, brings together leaders from the biotechnology, pharmaceutical and investment communities. Mycovia earned the opportunity to present at the conference through the “Buzz of BIO” competition, as the company was recognized as a Late Stage Leader by popular vote in September.